# High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study

> **NCT01926132** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Fatigue

## Interventions

- **DRUG:** ascorbic acid 10g/20ml
- **DRUG:** Normal Saline 150ml

## Key facts

- **NCT ID:** NCT01926132
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926132, "High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01926132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*